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ARTICLE
Dynamic control of neurochemical release with
ultrasonically-sensitive nanoshell-tethered
liposomes
Sean M. Mackay 1, David Mo Aung Myint1, Richard A. Easingwood 2,3, Dylan Y. Hegh1,
Jeffery R. Wickens 4, Brian I. Hyland 5, Guy N.L. Jameson 1,6, John N.J. Reynolds 2 & Eng Wui Tan 1*
The unique surface plasmon resonance of hollow gold nanoshells can be used to achieve drug
release from liposomes upon laser stimulation, and adapted to mimic the intricate dynamics
of neurotransmission ex vivo in brain preparations. However, to induce a physiological
response in vivo requires the degree of temporal precision afforded by laser stimulation, but
with a greater depth of penetration through tissue. Here we report that the attachment of
hollow gold nanoshells to the surface of robust liposomes results in a construct that is highly
sensitive to ultrasonic stimulation. The resulting construct can be remotely triggered by low
intensity, therapeutic ultrasound. To our knowledge, this is the first example of nanoparticle-
liposome system that can be activated by both laser and acoustic stimulation. The system is
capable of encapsulating the neurochemical dopamine, and repeatedly releasing small
amounts on-demand in a circulating environment, allowing for precise spatiotemporal control
over the release profile.
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Advances in nanotechnology-based delivery vehicles haveresulted in promising systems towards achieving drugrelease locally with precise temporal control. Liposomes
are widely used as drug delivery systems as they possess the ability
to achieve localised delivery of a therapeutic agent1,2, for example,
in cancer therapy, where accumulation and subsequent prolonged
drug release is desired in the tumour microenvironment3,4. In
addition to localisation, temporal control over the release profile
of a therapeutic agent would be desirable to allow for drug release
that mimics natural biological patterns. Such an approach could
lead to improved treatments for neurological disorders, including
Parkinson’s disease, where some of the movement disorder is
attributed to the temporal pattern of dopamine receptor
stimulation5,6.
One promising nanoparticle system which allows for precise
temporal control is the addition of near-infrared (NIR) absorbing
hollow gold nanoshells (HGNs) to the surface of liposomes7. This
system can be remotely activated via irradiation with a NIR laser
to achieve payload release from the liposome carrier in either a
near total7, or repeatable non-destructive manner8, dependent on
the number of HGNs attached and laser intensity. Recently, we
adapted this system to achieve sub-second release of dopamine in
a manner which mimics the natural dynamics of neuro-
transmitter release in the brain upon femtosecond laser
stimulation9,10. The precision afforded by laser stimulation can
repeatedly induce localised and neurochemical-dependent phy-
siological effects. Moreover, these effects can be elicited after a
month of direct implantation into neural tissue demonstrating
long-term in vivo stability of the system10. This is a significant
step towards potentially restoring these processes in conditions of
neurological dysfunction, but remains limited by the depth of
penetration of light into tissues. Ultrasound has also been used in
a similar capacity for stimulating drug release from liposomes11.
Since laser-stimulated release from HGN–liposome systems has
been attributed to a mechanism similar to that underlying
ultrasound release7, we hypothesised that the system developed
for laser use could be further developed to release using ultra-
sound at therapeutic frequencies.
Ultrasound is widely accepted in clinical medicine for both
diagnostic and therapeutic applications, and unlike NIR light, can
achieve deep penetration into mammalian tissues12. Nearly all
ultrasound-responsive drug delivery systems involve gas-
containing vesicles, for example, microbubbles, which can facil-
itate leakage from drugs encapsulated within carrier particles in
close proximity, or co-encapsulated within the microbubble
itself13–16. To date, however, there are few examples of methods
that sensitise the delivery vehicle itself to ultrasound. Those that
have been developed all involve the addition of membrane-
compromising agents, such as 1,2-dioleoyl-sn-glycero-3-phos-
phoethanolamine (DOPE)17. These existing ultrasound stimu-
lated systems have a number of limitations, namely the large size
and need for co-location with the drug-containing reservoir in the
case of microbubbles, and compromised membrane integrity
leading to poor entrapment efficiency. Furthermore, these sys-
tems have largely been designed to achieve the total or near-total
release in response to a single ultrasound application. However, to
achieve in vivo restoration of neurochemical dynamics requires
the development of a stable system which can incrementally
release small quantities of an encapsulated agent with precise
control.
Here, we demonstrate a method of increasing the suscept-
ibility of a liposome construct to ultrasound through the
attachment of nanoparticles to the surface of a stable liposome
membrane. In particular, we show that tethering hollow gold
nanoshells to the liposomes results in a highly sonosensitive
construct and propose a mechanistic basis for the phenomenon
observed. We then show the ability of the system to release the
neurochemical dopamine in a pulsatile manner within a circu-
lating system. To our knowledge, this is the first demonstration
of a liposome–nanoparticle system capable of on-demand trig-
gered release in response to both laser9 and acoustic stimulation.
Results
Gold nanoshells enhance liposome ultrasound sensitivity. To
investigate the effect of nanoparticles on the acoustic sensitivity
of liposomes, biocompatible liposome structures containing a
thiol linker moiety (tether-ready liposomes) were prepared
based on a previous publication9, and tethered to either solid
gold nanoparticles (SNPs) or HGNs. A thin-film of 1,2-dipa-
mitoyl-sn-glycero-3-phosphotidylcholine (DPPC), cholesterol,
sphingomyelin, 1,2-distearoyl-sn-glycero-3-phosphoethanola-
mine-N-[methoxy(polyethylene glycol)-2000] (DSPE-PEG2000)
and DSPE-2000-SH in a 100:5:5:4:3.5 molar ratio was pre-
pared18, and rehydrated with phosphate buffered carboxy-
fluorescein (CF) (100 mM CF, 20 mM Na2HPO4, pH 7.4) to
form a lipid suspension containing large multilamellar vesicles.
Size control of the liposome suspension was achieved by
extrusion through 200 -nm polycarbonate membranes. Ellman’s
assay19 was used to quantify the number of accessible thiol
moieties per liposome. The concentration of DSPE-PEG2000-
SH detected was ~50% of the total DSPE-PEG2000-SH present
in suspension (Supplementary Note 1, Supplementary Table 4),
suggesting that the DSPE-PEG2000-SH is distributed equally
between the inner and outer leaflet of the liposome membrane.
SNPs were synthesised to ~25 nm in diameter (Supplementary
Fig. 1) by the commonly used citrate reduction method20. HGNs
(Supplementary Fig. 2) were synthesised by galvanic replacement
of a silver nanoparticle template, as previously described7,21.
Cryo-transmission electron microscopy (cryo-TEM) and electron
tomography confirmed that the HGNs were hollow in nature
(Fig. 1a and inset) with a diameter of ~25–35 nm.
The nanoparticle suspensions were added periodically in 10 μL
additions to a suspension of tether-ready liposomes to achieve a
nanoparticle:lipid (mg/mmol) ratio of 55:1 and 65:1 for HGN–
and SNP–liposomes, respectively, which resulted in stable
liposome–nanoparticle constructs containing CF. The liposome
suspensions were diluted 1:10 with phosphate buffer (20 mM, pH
7.4) and left to tether for 96 h. At these ratios, ~1 or 2
nanoparticles per liposome on average was observed by cryo-
TEM (Fig. 1a).
Fluorescence intensity was measured after low intensity
therapeutic (1 MHz) ultrasound was applied to the diluted
suspension (1W cm−2, 0.38 ± 0.02 MPa, 100% duty cycle) for
4.5 s every 3 min (Fig. 1b). Application of ultrasound to liposomes
caused release of small amounts of CF upon multiple 4.5 s
exposures (~5% release, 30 pulses over 90 min), which was
enhanced by the attachment of SNPs (~13% release, 30 pulses
over 90 min). However, ultrasound applied to liposomes tethered
to HGNs resulted in a large increase in the percentage of CF
released when ultrasound was applied to the suspension,
achieving ~65% release after an equivalent exposure period to
SNP–liposomes and tether-ready liposomes. Furthermore, the
profile of release appears to level off, suggesting that magnitude of
release per ultrasound application is proportional to the total
amount of encapsulated CF remaining within the system. In
contrast, when HGNs were merely co-dispersed with liposomes
without the inclusion of the DSPE-PEG2000-SH tethering agent,
no difference in CF release was observed in the presence of HGNs
compared with control liposomes after acoustic stimulation
(Supplementary Fig. 3). No appreciable release of carboxyfluor-
escein was observed in the absence of ultrasound, and the
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liposomes were resistant to leakage at an elevated temperature
of 34 °C over a period of 76 h (~0.2% release per hour, ~5% after
23 h) (data not shown).
TEM of the suspensions after the period of ultrasound
irradiation (Fig. 1b inset) shows that the liposome structures
remain both largely intact and tethered to the HGNs, suggesting a
relatively non-destructive mechanism of release. A relationship
between the magnitude of CF release from HGN-tethered and
SNP-tethered liposomes and tethering time appeared to exist.
Sixty seconds of accumulated ultrasound exposure resulted in
~3.5% and 6% CF release for 18 and 96-h tethering time, and ~6
and 45% CF release after 18 and 96 h tethering time for
SNP–liposomes and HGN–liposomes, respectively (Fig. 1b red
inset). In contrast, little difference in the magnitude of release was
observed in tether-ready liposomes containing no gold nanopar-
ticles over time after the same period of applied ultrasound (2% vs
3% after 18 and 96 h). HGN-tethered liposomes have previously
been shown to produce total CF release upon laser irradiation,
through localised heating and subsequent cavitation at the
liposome surface7,8,22. However, to our knowledge, this is the
first demonstration that liposomes tethered to HGNs possess a
dramatically increased susceptibility to ultrasound.
Peak ultrasound sensitivity occurs with one hollow nanoshell.
The addition of HGNs to the solution of tether-ready liposomes
resulted in a complex mixture of species suspended in solution, as
evident by cryo-TEM of the suspensions. Therefore, it was of
interest to identify which of the resulting nanoparticle–liposome
conjugate species lead to the greatest enhancement in sono-
sensitivity. A variation of Job’s method23 was used to investigate
the liposome–nanoparticle dynamics occurring within the com-
plex sonosensitive suspension. Increasing concentrations of
HGNs were added to a fixed liposome concentration. Liposomes
were prepared containing CF as previously described, however,
sphingomyelin was omitted as a membrane component due to the
high encapsulation efficiency of CF. Volumes of a HGN sus-
pension (0–250 μL; 8 mg mL−1 Au concentration, Supplementary
Table 2) were added to equal volumes of liposome suspension
and stored at 4 °C overnight (~18 h) for tethering to occur.
Therapeutic ultrasound was applied to each of the diluted
HGN–liposome suspensions for 3 s with 3-min intervals between
each application. The temperature of the suspension after
ultrasonication did not change appreciably from room tempera-
ture (23–25 °C), well below the temperature required to initiate
leakage (35 °C). A significant increase (~fivefold over 15 s
accumulated exposure) in the amount of CF released with
increasing accumulated exposure time was observed for those
suspensions containing 50 and 100 µL of a HGN suspension,
when compared with control liposomes containing no HGNs
(Fig. 2a). However, a decreasing trend in the percentage of CF
released was observed for liposome–HGN constructs containing
150 μL or more of the HGN suspension. The Z-average and
polydispersity index of the suspensions also increased with HGN
additions 100 µL and greater, suggesting an increase in the degree
of aggregation present (Supplementary Fig. 4). An asymptotic
effect on the Z-Average is observed in suspensions with 150 µL
and greater, which suggests that although aggregation occurs at
these ratios, the size of the aggregates may not necessarily be
governed by the amount of HGNs present. It should also be noted
that no peaks were observed between 20 and 40 nm in the DLS,
suggesting that all HGNs were associated with liposomes
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Fig. 1 Influence of gold nanoparticles on the acoustic sensitivity of liposomes. a Example of a cryo-transmission electron micrograph of HGN–liposomes.
Red insert: An example of a 30 -nm hollow gold nanoshell obtained from the image by cryo-transmission electron tomography. Scale bar= 100 nm.
b Average (± standard error) percentage CF release after 96-h tethering time, measured by an increase in florescence intensity (ex 465, em 520 nm) upon
s exposure to ultrasound (4.5 s duration, every 3 min; n= 3 experiments; total experiment run time of ~93 min) and normalised to complete CF release by
Triton X-100 for tether-ready (control) liposomes (blue diamonds), SNP–liposomes (red squares) and HGN–liposomes (green triangles). The total CF
concentration in suspension after complete release is ~8 ± 1 μM. Red insert: Percentage CF release after 18 h tethering time (y- and x-axis represent
percentage fluorescence and accumulated exposure time (s), respectively). c TEM of HGN–liposomes after 100 s ultrasound application. Scale bar=
500 nm
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(Supplementary Fig. 5). Cryo-TEM confirmed the presence of
aggregates in the higher HGN suspensions (Supplementary
Fig. 6).
Figure 2b illustrates micrographs of all suspensions with
incremental additions of HGNs revealed a range of species; bare
liposomes, untethered HGNs, liposomes containing one tethered
HGN, liposomes containing multiple tethered HGNs and
HGN–liposome clusters. Figure 2c shows the quantification of
species as a population percentage (details further described in
Supplementary Note 2, Supplementary Tables 2 and 3). Few
untethered HGN particles were evident, especially in the
suspensions containing the smaller volumes of HGNs. In the
suspensions displaying the greatest enhancement in sonosensi-
tivity bare liposomes and HGN–liposomes consisting of approxi-
mately one tethered HGN particle per liposome were most
evident, with clusters emerging in the 100 µL sample, which was
corroborated by DLS. As the Z-average and PDI were lowest in
the suspensions which displayed the greatest sensitivity to
ultrasound, and as these suspensions contained the highest
proportion of liposomes containing one tethered HGN, it is
reasonable to assume that these criteria are critical for optimising
ultrasound-induced release.
Clusters and constructs consisting of multiple HGNs per
liposome were more prevalent in the suspensions with greater
HGN concentrations. Such clusters presumably form through the
reaction of HGNs attached at the outer surface of the liposome
membrane with unbound thiols moieties of neighbouring
liposomes. The number of clusters visible by cryo-TEM appears
to decrease between samples containing 150–250 μL of HGN
suspension (Fig. 2c), however, the Z-average and polydispersity
index of the samples show an increase within the same interval
(Supplementary Fig. 4). This likely reflects an increase in the size
of HGN–liposome clusters. The increase in cluster formation at
higher HGN concentrations is well correlated with the observed
inhibition in CF release. To investigate relationship between
clustering and CF release, we extended the polyethylene glycol
steric boundary by the inclusion of 1 mol% DSPE-PEG5000 in the
liposome. This sufficiently prevented cluster formation with a
HGN to liposome ratio of ~1:1 and resulted in an ~25% increase
in the enhancement in sonosensitivity (Supplementary Table 1,
Supplementary Fig. 7). The increased CF release observed
supports our proposition that clustering inhibits ultrasound
sensitivity in this HGN–liposome system.
Cryo-electron tomography of HGN-conjugated liposomes. To
investigate any morphological changes to the liposome structure
that may be imparted through the addition of hollow or solid gold
nanoparticles, cryo-transmission electron tomography was per-
formed on the nanoparticle–liposome conjugates (Cryo-TEM
images Supplementary Fig. 8). Control liposomes with no
nanoparticle conjugation displayed a typical symmetrically
spherical morphology (Fig. 3aI). Co-dispersion and incubation of
HGNs or SNPs with a suspension of tether-ready liposomes for
18 h resulted in successful attachment of nanoparticles to the
liposome surface, confirmed by DLS by an increase in hydro-
dynamic diameter. Analysis of the reconstructed tomogram
volumes allowed for locational analysis of the nanoparticles in
relation to the liposome surface. This showed that the nano-
particles were co-located at the liposome surface in three-
dimensional space, in agreement with the DLS analysis (Supple-
mentary Fig. 5). In most cases, it was evident that HGNs were
situated at a distance of ~3 nm from the liposome surface
(Fig. 3aII). In the HGN–liposome sample after 18 h of tethering, it
was also evident that in some cases, a number of particles adhered
to the exterior surface of the liposome, inducing a marginal
indentation into the liposome membrane (Fig. 3aIII), which
became more pronounced after 96 h post conjugation (Fig. 3aIV,
V). In contrast, in all cases of liposomes conjugated to two or
more HGNs (Fig. 3b) and liposomes conjugated to one SNP
(Fig. 3c), the conjugated nanoparticle appeared co-located with
the liposome surface with a consistent space of ~3–4 nm at 96 h
post conjugation. This morphological change observed in
HGN–liposomes, but absent in SNP–liposomes, suggests a pos-
sible nanoparticle-directed membrane rearrangement and may
in-part account for the enhanced acoustic sensitivity observed.
Ultrasound threshold effect of HGN–liposomes. The intensity
of ultrasound applied to tissue is an important consideration for
biological and clinical application. Therefore, the effect of
hydrostatic pressure (and thus, mechanical index) on CF release
was investigated. In general, the incidence of inertial cavitation in
an ultrasonic field increases with ultrasound intensity and
hydrostatic pressure22. It was hypothesised that if the addition of
HGNs leads to an increase in cavitation, the enhancement effect
should increase with increasing ultrasound intensity. Liposomes
encapsulating CF were prepared as previously described with a
tethering period of 18 h, and cryo-TEM confirmed the attach-
ment of HGNs to tether-ready liposomes, with a ratio of
approximately one HGN per liposome.
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Fig. 2 Particle number influences acoustically driven release from
liposomes. a Total cumulative CF release from liposomes tethered to 0 μL
(blue), 50 μL (orange), 100 μL (grey), 150 μL (yellow), 200 μL (purple) and
250 μL (green – on x-axis) of a HGN suspension (8mgmL−1) in response
to 15 s of ultrasound application (2.4W cm−2, 0.64MPa, 100% duty
cycle). The data represent average ± standard error. The total CF
concentration in suspension is ~5.7 ± 0.2 μM. b Exemplar cryo-TEM of a
suspension of HGN–liposomes indicating bare liposomes (green arrow),
liposomes tethered to one HGN (blue arrow), liposomes tethered to
multiple HGNs (orange arrow) and clusters of HGN–liposomes (red arrow).
Scale bar= 200 nm. c Analysis of the relative proportions of different
species present within a HGN–liposome suspension, including liposomes
tethered to one HGN (grey), liposomes tethered to multiple particles
(yellow), and HGN–liposome clusters (blue)
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Ultrasound was applied to both control liposomes and
HGN–liposomes, resulting in an increase in the percentage of
CF released with increasing intensity (Fig. 4a, b). However, the
percentage of CF released from control liposomes was marginal
compared with that of the HGN-tethered liposomes, with
maximal release reaching only 1% at an acoustic pressure of
0.64MPa. Comparing the ratio of CF release from HGN-tethered
liposomes to control liposomes revealed no apparent difference in
the percentage of CF released upon irradiation with an acoustic
pressure of 0.18MPa (Fig. 4c). However, an enhancement in the
sonosensitivity of HGN-tethered liposomes compared with
control liposomes was evident at acoustic pressures of 0.3, 0.48
and 0.64MPa, which correspond to a ~2.5-fold increase in the
percentage of CF released from the system. This suggests that the
addition of HGNs to the membrane surface decreases the acoustic
energy required to elicit release, and that an ultrasound threshold
energy must be met in order to observe any enhancement in
sonosensitivity. Interestingly, the ratio of rate of release from
HGN-tethered and control liposomes remained constant (2.5 ±
0.2-fold) for all acoustic pressures above a clear 0.2–0.3 MPa
energy threshold (Fig. 4d). As the magnitude of enhancement
does not appear proportional to ultrasound intensity, this may
a b c
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V
Fig. 3 Cryo-electron tomography of typical HGN–liposomes reconstructed using IMOD and Chimera software packages. a Control liposome (I), liposomes
conjugated to one HGN after 18 h (II and III. Note that in (III) the liposome encapsulates a smaller liposome) and liposomes conjugated to one HGN after
96 h (IV and V). b HGN–liposomes containing two tethered HGNs after 96 h. c Liposomes conjugated to SNPs after 96 h. Scale bars represent 100 nm
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Fig. 4 Influence of acoustic pressure on release from HGN–liposomes. a % CF released, determined by fluorescence intensity, from HGN-conjugated
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threshold acoustic pressure (red bar) required to accelerate the rate of CF release. The data represent average ± standard error (n= 3). Total concentration
of CF in suspension is ~7.5 ± 0.2 μM
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suggest that HGNs impart ultrasound sensitivity to liposomes in a
non-cavitational manner.
On-demand spatiotemporal release of dopamine. Dopamine, an
important neurotransmitter in the body and in the brain, plays
multiple roles in reward and motivation24–26. Abnormalities of
dopamine release are associated with several diseases, including
Parkinson’s disease, where there is death of dopamine-containing
neurons. Dopamine is normally released with very specific tem-
poral dynamics27, and so truly biomimetic replacement strategies
may require similarly phasic release patterns. The ability to
modulate neurochemical activity with dynamic control is cur-
rently a challenge of significant interest. Thus, our next experi-
ments investigated the potential of our sonosensitive HGN-
tethered liposome system to release dopamine in a temporally
controlled manner into a circulating system designed to mimic
blood flow.
Dopamine was encapsulated within liposomes using the
formulation and procedure previously used for the encapsulation
of CF, and stabilised against oxidation with equimolar amounts of
L-ascorbic acid. Cyclic voltammetry was used to detect the
concentration of non-encapsulated dopamine within the lipo-
some suspension at an oxidation potential of ~0.38 V. The
effectiveness of the technique was unaffected by the presence of
liposomes or HGNs within the samples. A significantly higher
peak in the voltammogram for each duration of ultrasound
applied was detected for HGN-conjugated liposomes compared
with non-tethered controls in response to ultrasound (Fig. 5a). A
linear increase in the release was observed for both HGN-tethered
and tether-ready liposomes, where successive release of dopamine
was sustained for prolonged ultrasound treatments, lasting over
25 individual applications (Fig. 5b).
In order to achieve minimal passive leakage of dopamine at the
elevated temperatures (>35 °C) required for subsequent ex vivo
investigations, DPPC in the lipid formulation was replaced with
1,2-disteraoyl-sn-3-glycero-phosphatidylcholine (DSPC) due to
its higher phase transition temperature. This reduced the levels of
spontaneous dopamine release. In vitro release experiments were
conducted at 35 °C with DSPC containing HGN-tethered
liposomes using a flow system consisting of a liposome reservoir,
peristaltic pump, ultrasound exposure chamber and recording
chamber (Fig. 5c). This system was designed to simulate drug
release in a flowing vascular system. The liposomes remained
stable with minimal leakage throughout numerous cycles of
ultrasound treatment over 2 days. Phasic micromolar increases in
the concentration of dopamine in the recording chamber was
achieved with repeated ultrasound exposures of 2–5 s or higher at
an intensity of 2.4W cm−2 (0.64 MPa; 100% duty cycle) (Fig. 5d).
No appreciable release of dopamine was observed in the absence
of ultrasound over the time period of the experiment (~80 min for
HGN-tethered liposomes and ~50 min for control non-tethered
liposomes).
Discussion
Given the insensitivity of traditional, sub-500 -nm unilamellar
liposomes to shear stress28 and ultrasound forces29, the addition
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Fig. 5 Detection of dopamine by cyclic voltammetry in response to ultrasound. a Representative cyclic voltammograms used to verify the presence of
dopamine released from liposomes. Top: non-tethered liposomes. Bottom: HGN-tethered liposomes. b Representative example of linear release of
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in a circulating flow system. Blue bars indicate a 9 s continuous ultrasound application at 2.4W cm−2 (0.64MPa) every 20 s
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of HGNs to the surface of a liposome presents a unique method
of sensitising robust liposome structures to acoustic stimulation.
Maximal release was achieved from monodisperse suspensions
when the liposomes were conjugated to approximately one
structurally hollow nanoparticle. An acoustic pressure threshold
of ~0.2 MPa was observed to elicit CF release. This is considerably
lower than that previously observed for sonosensitive liposomes
containing DOPE under identical ultrasound conditions30,
without the need for membrane-compromising additives. In
addition, release appears to occur in a primarily non-destructive
manner, with evidence of intact HGN-tethered liposomes after
the application of ultrasound visible by TEM. Therefore, as a
consequence of these observations we believe that the primary
mechanism of release in this HGN–liposome system is likely non-
cavitational in nature.
A relationship was observed between HGN–liposome tethering
time and the subsequent susceptibility to ultrasound, which was
not observed in liposomes tethered to SNPs. Cryo-electron
tomography (cryo-TEM) of the liposomes tethered to one HGN
or SNP over a 96-h period revealed an intriguing sequence of
events. Approximately 18 h post conjugation, in most cases, a
small ~3–4 -nm space was visually apparent between the lipo-
some and the HGN or SNP surface, consistent with the length of
a 2000 Da polyethylene glycol chain extending from the mem-
brane surface at 7 mol% PEGylation31. Therefore, as the total
degree of PEGylation (DSPE-PEG2000 and DSPE-PEG2000-SH)
was 7.5 mol%, the ~3–4 -nm space between the HGN and lipo-
some surface likely corresponds to the length of the 2000 Da
polyethylene glycol chain protruding from its surface. After 96 h,
HGNs in the single HGN–liposome population appeared to
adhere to the liposome surface resulting in a minor indentation
within the liposome membrane; a phenomenon not observed
when multiple HGNs are attached to the same liposome.
Based on the time-dependant change in morphology observed
in HGN–liposomes, we propose that initial rapid binding of
DSPE-PEG2000-SH to a neighbouring HGN occurs, followed by
slow lateral translocation of the remaining thiol-derived lipids.
This results in multiple points of attachment to the single HGN
and leads to stronger adherence to the lipid membrane (Fig. 6).
The lateral translocation and cumulative binding of thiol-derived
phospholipids would likely produce a DSPE-PEG2000-SH-
enriched domain beneath the point of nanoparticle attachment.
In the case where multiple HGNs are bound, each HGN would
receive only a portion of the fixed number of DSPE-PEG2000-SH
linkages available within the membrane, creating a weaker
attraction to the liposome surface. Contrary to what might be
expected, this phenomenon was absent when SNPs are used in
place of HGNs demonstrating a critical requirement for the
hollow nanostructure. This may result from the increased
available surface area, porosity and defects creating a more
reactive surface32. It is proposed that this process of HGN-
mediated phospholipid ordering may be akin to the migration of
clathrin proteins during endocytosis of a particle, where diffusive
mobile receptors wrap around a ligand-coated particle33. How-
ever, due to the steric and geometric constraints of a 150–200 -nm
phospholipid membrane, and particularly the DSPE-PEG2000
component, the membrane wrapping of the HGN is limited to the
marginal indentation observed.
Further understanding of this phenomenon can be achieved by
considering the size of the spherical cap that would be occupied
by co-localised DSPE-PEG2000-SH phospholipids. An estimate
of the number of phospholipids in a 200 -nm liposome can be
made by considering the surface area of the inner and outer
leaflets of the liposome, and the weighted average lipid headgroup
surface area of the membrane constituents. For example, the
spherical cap of a liposome directly beneath a 30 -nm nano-
particle can be calculated to occupy 2900 nm2 of surface area on
the outer membrane leaflet. Furthermore, assuming a weighted
average lipid headgroup surface area of 0.68 nm2, the number of
phospholipids within a 200 -nm liposome would be 351580; of
which 5236 are DSPE-PEG2000-SH molecules residing in the
outer liposome leaflet. Due to the larger headgroup surface area of
1.4 nm234, this would occupy 7330 nm2 of the liposome surface.
Therefore, when only one nanoparticle is conjugated to a lipo-
some surface, the available surface area occupied by completely
agglomerated DSPE-PEG2000-SH is ~2.5 times that of the surface
cap beneath an attached nanoparticle, enabling strong adhesion
of the particle to the membrane domain, resulting in indentation
of the nanoparticle into the liposome surface and discontinuity of
the membrane structure. As the number of attached nanoparticles
increases, the DSPE-PEG2000-SH surface area available for
nanoparticle conjugation decreases, and consequently, so does the
strength of nanoparticle adhesion to the DSPE-PEG2000-SH
enriched domain. We propose that the increased binding inter-
actions between a HGN to DSPE-PEG2000-SH enriched mem-
brane domains and the resulting inhomogeneity and
discontinuity of the membrane structure imparted through this
phenomenon may account for the origin of acoustic sensitivity in
HGN–liposome systems.
A change in volume of a lipid vesicle in response to pressure
fluctuations has previously been observed and attributed to water
exit from the vesicle during pressure loading35. We further pro-
pose that under ultrasound conditions, pressure fluctuations
would be expected to cause contraction and expansion of the
liposome, albeit to a small degree dependant on the amplitude of
the ultrasound wave. As a region of the external liposome surface
is attached to the much more rigid gold nanoparticles surface,
the resulting push–pull effect would generate shear stress at
Fig. 6 Schematic illustration of the mechanism proposed for the indentation of HGNs within the liposome membrane over time. Initial binding of an HGN
(blue) to a DSPE-PEG2000-SH tethering agent (red) occurs rapidly, and subsequently, lateral translocation of the remaining DSPE-PEG2000-SH linkers
can occur over time, resulting in multiple binding events to the same HGN, increasing the affinity between the liposome membrane and HGN surface,
ultimately resulting in an indentation of the particle within the membrane surface. Note that red phospholipids agglomerate beneath the nanoparticle to
form the “spherical cap” of the liposome
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the HGN–liposome interface facilitating release of the encapsu-
lated agent. Further investigation is required to test this proposed
mechanism of enhanced sonosensitivity in HGN–liposomes.
It is also interesting to note that no increase in CF release was
observed in response to ultrasound when a HGN population was
merely co-dispersed with a liposome suspension without the
inclusion of a thiol-derived phospholipid, unlike that observed by
Wu et al. when investigating laser triggered release of CF from
HGN-conjugated liposomes7. This phenomenon was attributed to
rapid heating of the HGNs, resulting in the transient formation
and collapse of vapour bubbles in the surrounding solution
occurring within the diffusional vicinity of neighbouring
untethered liposomes. In addition, other nanoparticle systems
have been used as cavitation nuclei, eliciting release from co-
dispersed liposomes within proximity of the peak bubble dia-
meter of the cavitation event36–40. Given that no release was
observed from liposomes co-dispersed with HGNs in this study, it
is postulated that the primary mechanism of release may be non-
cavitational in nature, and rather the result of acoustic pressure
and shear forces disrupting the boundary of a DSPE-PEG2000-
SH-enriched lipid domain beneath the point of nanoparticle
attachment, possibly leading to transient pore formation and
release34,41,42.
We have demonstrated incremental release of encapsulated
agents over prolonged periods of ultrasound application, and
recorded phasic changes in dopamine concentrations within a
circulating system. Phasic as opposed to continuous release of
bioactive agents has implications for the improved treatment of a
variety of diseases, including cancer43, osteoporosis44,45 and
neurological disorders10. Existing ultrasound and NIR-releasing
systems, such as DOPE liposomes17 and pramipexole PLGA
microspheres46, use minutes of stimulus to create phasic or step-
wise concentration changes on an hour timescale. In contrast, the
HGN–liposome system can be activated with both NIR9,10 and
ultrasound stimuli on a second timescale to create burst con-
centrations lasting for seconds to minutes. This timescale and
release profile is comparable with the rhythmic release of neu-
rotransmitters and neuromodulators in the brain47,48. We envi-
sage this nanoparticle system functioning as an inertly circulating
drug reservoir which is intravenously injected, and activated via
focal application of ultrasound. Upon activation with temporally
controlled ultrasonic pulses, repeated bursts of blood–brain-bar-
rier permeable neurochemical modulators are released into the
brain vasculature, cross the blood–brain barrier and elicit or
restore an appropriate neurochemical response. Our future intent
is to demonstrate the applicability of this technology in control-
ling neurochemical activity in vivo in models of neurological
disease, initially using models of epilepsy and Parkinson’s disease.
This system is anticipated to be well-tolerated as liposomes are
biocompatible and HGNs have to-date demonstrated minimal
cytotoxicity49 and have been shown to break down in human
blood serum32, providing a potential pathway for degradation
and elimination. The development of drug-release technologies
that can accurately mimic these temporal profiles may provide a
new avenue towards biomimetic therapeutics, where the release
profile of the therapeutic agent can be tailored to interface with an
endogenous process and restore normal function.
Methods
Preparation of liposomal nanostructures. All chemicals and drugs were pur-
chased from Sigma Aldrich, and phospholipids from Avanti Polar Lipids and
Laysan Bio, and used without further purification or modification. Carboxy-
fluorescein was purchased from Molekula. Hollow gold nanoshells were prepared
as per a previously reported procedure by Prevo et al.20. Solid gold nanoparticles
were prepared via the citrate reduction method, as previously described by Mar-
inakos et al.19. Both nanoparticle suspensions were stabilised to aggregation by
surface derivatization with a 750 Da thiol-derived polyethylene glycol at a ratio of
~1:7 and 1:10 mmol/mmol for HGNs and SNPs, respectively, and concentrated by
centrifugation at 10,000 rcf. All final concentrated gold nanoparticle suspensions
were analysed by inductively coupled plasma mass spectrometry (ICP-MS) to
quantify the total gold concentration in the suspension. The 750 Da thiol-derived
polyethylene glycol was synthesised through the reaction of methoxypolyethylene
glycol amine (750 Da) with 2-iminothiolane in a 1:2 mol ratio in 3 mM sodium
phosphate buffer at pH 9.3. The thiol-derived DSPE-PEG-2000 phospholipid used
for nanoparticle conjugation as previously described from 1,2-distearoyl-sn-gly-
cero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-2000] (sodium salt)
(DSPE-PEG2000-NH2) using 2-iminothiolane in a 1:2 mol ratio in 3 mM phos-
phate buffer at pH 9.39.
Liposomal nanostructures were prepared using the thin-film rehydration
method as previously described, using a phospholipid composition comprising
either 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) or 1,2-distearoyl-sn-
glycero-3-phosphocholine (DSPC) with cholesterol, sphingomyelin, DSPE-
PEG2000 and DSPE-PEG2000-SH in a 100:5:5:4:3.5 mol ratio9,10. The lipid
components were dissolved in chloroform, combined in the appropriate ratios and
the solvent removed in vacuo to form a lipid film. The film was then re-suspended
using the appropriate volume of an aqueous solution containing phosphate buffer
(20 mM Na2HPO4, pH 7.4) containing carboxyfluorescein, dopamine or
apomorphine. In the case of dopamine or apomorphine, ascorbic acid (2 mgmL−1)
or sodium metabisulfite (1 mgmL−1) was included in the aqueous solution to
prevent oxidation of the bioactive agent. The phospholipid suspension was
extruded 15 times through 200 -nm polycarbonate membranes to achieve size-
controlled unilamellar vesicles. Excess dye or drug was subsequently removed via
dialysis. All samples were subjected to DLS analysis after manufacture and before
use to characterise size distribution and stability to aggregation.
General procedure for ultrasound release studies in vitro. Ultrasound release
studies were performed measuring the percentage fluorescence of self-quenching
fluorophore carboxyfluorescein on a Perkin-Elmer LS50B luminescence spectro-
meter, using an excitation wavelength of 465 nm, emission wavelength of 520 nm,
slit width of 2.5 nm and integration time of 0.5 s. Fluorescence intensity mea-
surements were recorded in a 3 × 1 quartz fluorescence cuvette at a scattering angle
of 90° containing 3 mL of a dilute liposome suspension (1 μM phospholipid con-
centration). The initial fluorescence intensity as measured over 30 s. Ultrasound
was then applied to face of the cuvette at various intensities, coupled to the
transducer with Aquasonic® ultrasound transmission gel and the fluorescence
intensity post-application subsequently measured. To obtain the final fluorescence
intensity, 100 μL of Triton-X100 (10% v/v) was added to the suspension. All release
experiments were performed at room temperature using liposomes composed of
the DPPC formulation. The percentage of CF released was determined by a change
in fluorescence intensity, and calculated as described below:
%CFReleased ¼ I  I0
I1  I0
ð1Þ
where I0 in the initial fluorescence intensity at t= 0, and I∞ is the fluorescence
intensity after total liposome lysis via the addition of Triton-X100.
Dopamine release was quantified by cyclic voltammetry. A nafion-coated
carbon fibre microelectrode (CFN30-1000) was used in conjunction with an
CompactStat potentiostat (Ivium Technologies, Netherlands) to measure dopamine
concentrations. A platinum counter electrode and an Ag/AgCl2 reference electrode
were also used. Cyclic voltammetry was performed at 0.5 V s−1 for five cycles in
each measurement. Baseline was subtracted from the voltammograms to measure
the height of peaks associated with dopamine oxidation. The baseline was the
voltammogram of HEPES buffer. Liposome suspensions (7–10 mL) were placed in
a sample tube and treated with ultrasound (1MHz, 3.0W cm−2) for durations of
4.4 s per application. After each treatment, the electrodes were immersed into the
liposome suspensions for measurement, and subsequently removed prior to the
next application of ultrasound. All release studies were performed at 35 °C using
liposomes composed of the DSPC formulation.
Electron microscopy and electron tomography. Conventional room temperature
TEM was used to image the isolated HGN and SNP preparations. A suspension of
the HGNs or SNPs in deionized water was applied to a carbon-coated copper mesh
grid and blotted. Images were captured using a Phillips CM100 transmission
electron microscope (Phillips Electron Optics, Eindhoven, The Netherlands), fitted
with a MegaView 3 camera (Soft Imaging System, GmbH, Münster, Germany).
Liposome–NP conjugates were observed by cryo-TEM, using a JEOL JEM-
2200FS transmission electron microscope with an omega energy filter (JEOL Ltd.,
Tokyo, Japan) and a Gatan 914 high-tilt cryo sample holder (Gatan Inc., CA, USA).
Specimens were prepared by adding 4 μL of the diluted liposome–NP suspension to
a Quantifoil® R2/2 sample grid, which had been rendered hydrophilic using a
BioRad E5100 SEM coating system modified in-house for glow discharging
(BioRad Microscience Ltd., Hertfordshire, UK). Excess sample was removed by
blotting the grid using the filter paper. The sample was then immediately plunge-
frozen into liquid ethane using a Reichert-Jung KF80 plunge freezing device
(Reichert Optische Werk AG, Vienna, Austria). The frozen samples were stored
under liquid nitrogen until viewing. Zero-loss energy filtered images were recorded
on the JEOL TEM using a TVIPS F416 CMOS camera (TVIPS GmbH., Germany).
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Data acquisition, including tilt series acquisition, was performed using Serial-EM
software, and the data processed using IMOD (Boulder Laboratory for 3-D
Microscopy, Colorado, USA), and Chimera (University of California San Francisco,
California, USA) software packages.
Data availability
All data are available from the corresponding author upon reasonable request.
Received: 25 July 2019; Accepted: 1 October 2019;
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